Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone

[1] Addington D(1994)Specificity of the Calgary Depression Scale for schizophrenics Schizophr Res 11 239-244

[2] Addington J(1992)The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology Arch Gen Psychiatry 49 615-623

[3] Maticka-Tyndale E(2010)Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs Biol Psychiatry 67 255-262

[4] Andreasen NC(1989)A rating scale for drug-induced akathisia Br J Psychiatry 154 672-676

[5] Flaum M(2011)Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature Aust N Z J Psychiatry 45 93-108

[6] Arndt S(2010)The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements Schizophr Bull 36 71-93

[7] Andreasen NC(2002)Another view of therapy for cognition in schizophrenia Biol Psychiatry 51 969-971

[8] Pressler M(2009)Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison J Clin Psychiatry 70 717-729

[9] Nopoulos P(2009)Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis Br J Psychiatry 194 439-445

[10] Miller D(2009)Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) Am J Psychiatry 166 675-682

[1] Addington D(1994)Specificity of the Calgary Depression Scale for schizophrenics Schizophr Res 11 239-244

[2] Addington J(1992)The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology Arch Gen Psychiatry 49 615-623

[3] Maticka-Tyndale E(2010)Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs Biol Psychiatry 67 255-262

[4] Andreasen NC(1989)A rating scale for drug-induced akathisia Br J Psychiatry 154 672-676

[5] Flaum M(2011)Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature Aust N Z J Psychiatry 45 93-108

[6] Arndt S(2010)The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements Schizophr Bull 36 71-93

[7] Andreasen NC(2002)Another view of therapy for cognition in schizophrenia Biol Psychiatry 51 969-971

[8] Pressler M(2009)Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison J Clin Psychiatry 70 717-729

[9] Nopoulos P(2009)Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis Br J Psychiatry 194 439-445

[10] Miller D(2009)Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) Am J Psychiatry 166 675-682